Panama vs Turkey: Mortality from CVD, cancer, diabetes or CRD between exact … female
Mortality from CVD, cancer, diabetes or CRD between exact … female over time
- Panama
- Turkey
How they compare
Turkey currently reports 10.1% against 9.4% in Panama, a difference of 0.7%.
That makes Turkey's figure about 1.1 times Panama's.
Across all 22 years both countries report, Turkey has been ahead every year.
Panama ranks 147th and Turkey ranks 145th of 185 countries.
Turkey has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Panama | Turkey | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.3% | 13.6% | 3.2% | Turkey |
| 2010s | 9.6% | 12.1% | 2.5% | Turkey |
| 2020s | 8.9% | 9.9% | 1.0% | Turkey |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mortality from cvd, cancer, diabetes or crd between exact ages 30 and, Panama or Turkey?
- Turkey, at 10.1% against 9.4% in Panama as of 2021.
- What is the difference in mortality from cvd, cancer, diabetes or crd between exact ages 30 and between Panama and Turkey?
- 0.7%, with Turkey ahead.
- How many years of comparable data are there for Panama and Turkey?
- 22 years are reported by both, from 2000 to 2021.
- How do Panama and Turkey rank globally for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
- Panama ranks 147th and Turkey ranks 145th of 185 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).